TIMOTHY RAMSEY: Open Payments
NPI 1669228078 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 39 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $428 |
| AstraZeneca Pharmaceuticals LP | 2 | $108 |
| Corcept Therapeutics | 2 | $57 |
| Novo Nordisk Inc | 3 | $53 |
| HARMONY BIOSCIENCES LLC | 2 | $44 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $43 |
| Viatris Specialty LLC | 2 | $35 |
| Gilead Sciences, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
Products named: VRAYLAR, QULIPTA, BREZTRI, Korlym, UBRELVY, Wegovy, WAKIX, JOURNAVX.
Industry payments across NC — which companies pay providers there.
